相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。An Adenoviral Vaccine Encoding Full-Length Inactivated Human Her2 Exhibits Potent Immunogenicty and Enhanced Therapeutic Efficacy without Oncogenicity
Zachary C. Hartman et al.
CLINICAL CANCER RESEARCH (2010)
The Hormone Receptor GUCY2C Suppresses Intestinal Tumor Formation by Inhibiting AKT Signaling
Jieru Egeria Lin et al.
GASTROENTEROLOGY (2010)
Efficacy of Linaclotide for Patients With Chronic Constipation
Anthony J. Lembo et al.
GASTROENTEROLOGY (2010)
Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain
H. Eutamene et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2010)
Efficacy and Safety of Once Daily Linaclotide Administered Orally for 12-Weeks in Patients With Chronic Constipation: Results From 2 Randomized, Double-Blind, Placebo-Controlled Phase 3 Trials
Anthony Lembo et al.
GASTROENTEROLOGY (2010)
Pilot Study on the Effect of Linaclotide in Patients With Chronic Constipation
Jeffrey M. Johnston et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis
M. P. Garin-Laflam et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2009)
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)
Eyad Elkord et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Lineage-Specific T-Cell Responses to Cancer Mucosa Antigen Oppose Systemic Metastases without Mucosal Inflammatory Disease
Adam E. Snook et al.
CANCER RESEARCH (2009)
Induction of p53-Specific Immunity by a p53 Synthetic Long Peptide Vaccine in Patients Treated for Metastatic Colorectal Cancer
Frank M. Speetjens et al.
CLINICAL CANCER RESEARCH (2009)
Up-Regulating the Hemeoxygenase System Enhances Insulin Sensitivity and Improves Glucose Metabolism in Insulin-Resistant Diabetes in Goto-Kakizaki Rats
Joseph Fomusi Ndisang et al.
ENDOCRINOLOGY (2009)
GUCY2C reverse transcriptase PCR to stage pN0 colorectal cancer patients
Alex Mejia et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Guanylyl cyclase C in colorectal cancer: susceptibility gene and potential therapeutic target
Jieru E. Lin et al.
FUTURE ONCOLOGY (2009)
Association of GUCY2C Expression in Lymph Nodes With Time to Recurrence and Disease-Free Survival in pN0 Colorectal Cancer
Scott A. Waldman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?
Igor M. Belyakov et al.
JOURNAL OF IMMUNOLOGY (2009)
Breaking into bone biology Serotonin's secrets
Clifford J. Rosen
NATURE MEDICINE (2009)
Harnessing the unique local immunostimulatory properties of modified vaccinia Ankara (MVA) virus to generate superior tumor-specific immune responses and antitumor activity in a diversified prime and boost vaccine regimen
James W. Hodge et al.
VACCINE (2009)
Lrp5 Controls Bone Formation by Inhibiting Serotonin Synthesis in the Duodenum
Vijay K. Yadav et al.
CELL (2008)
Pilot study of vaccination with recombinant CEA-MUC-1-TRICOM poxviral-based vaccines in patients with metastatic carcinoma
James L. Gulley et al.
CLINICAL CANCER RESEARCH (2008)
Colorectal Cancer Is a Paracrine Deficiency Syndrome Amenable to Oral Hormone Replacement Therapy
Peng Li et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2008)
Uroguanylin, an intestinal natriuretic peptide, is delivered to the kidney as an unprocessed propeptide
Nicholas G. Moss et al.
ENDOCRINOLOGY (2008)
Helper T-Cell Responses and Clinical Activity of a Melanoma Vaccine With Multiple Peptides From MAGE and Melanocytic Differentiation Antigens
Craig L. Slingluff et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sildenafil citrate as a phosphodiesterase inhibitor has an antioxidant effect in the blood of men
H. Perk et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2008)
Guanylyl cyclase C-induced immunotherapeutic responses opposing tumor metastases without autoimmunity
Adam E. Snook et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production
Penny Y. T. Wang et al.
NATURE (2008)
Colonic crypt organization and tumorigenesis
Adam Humphries et al.
NATURE REVIEWS CANCER (2008)
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
Richard Gray et al.
LANCET (2007)
Cancer mucosa antigens as a novel immunotherapeutic class of tumor-associated antigen
A. E. Snook et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Homeostatic control of the crypt-villus axis by the bacterial enterotoxin receptor guanylyl cyclase C restricts the proliferating compartment in intestine
Peng Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Is occult lymph node disease in colorectal cancer patients clinically significant? A review of the relevant literature
Daniel G. Nicastri et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
The paracrine hormone hypothesis of colorectal cancer
G. M. Pitari et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome
Viola Andresen et al.
GASTROENTEROLOGY (2007)
Phosphodiesterase inhibitors and inflammatory bowel disease: emerging therapies in inflammatory bowel disease
Ali Keshavarzian et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity
Peng Li et al.
GASTROENTEROLOGY (2007)
Mucosally restricted antigens as novel immunological targets for antitumor therapy
Adam E. Snook et al.
BIOMARKERS IN MEDICINE (2007)
Adjuvant treatment of colorectal cancer
Brian M. Wolpin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
The morphogenetic code and colon cancer development
Gijs R. van den Brink et al.
CANCER CELL (2007)
Beneficial effect of phosphodiesterase-5 inhibitor in experimental inflammatory bowel disease; Molecular evidence for involvement of oxidative stress
Pooneh Khoshakhlagh et al.
TOXICOLOGY MECHANISMS AND METHODS (2007)
Gut hormones and the regulation of energy homeostasis
Kevin G. Murphy et al.
NATURE (2006)
The prognostic effect of micrometastases in previously staged lymph node negative (N0) colorectal carcinoma: A meta-analysis
Douglas Iddings et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
A validated quantitative assay to detect occult micrometastases by reverse transcriptase-polymerase chain reaction of guanylyl cyclase C in patients with colorectal cancer
Stephanie Schulz et al.
CLINICAL CANCER RESEARCH (2006)
Molecular characterisation of non-absorptive and absorptive enterocytes in human small intestine
N. Gassler et al.
GUT (2006)
In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E-coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers
Michael F. Giblin et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
The putative tumor suppressor Cdx2 is overexpressed by human colorectal adenocarcinomas
ME Witek et al.
CLINICAL CANCER RESEARCH (2005)
Interruption of homologous desensitization in cyclic guanosine 3′,5′-monophosphate signaling restores colon cancer cytostasis by bacterial enterotoxins
GM Pitari et al.
CANCER RESEARCH (2005)
Prevalence and demographics of irritable bowel syndrome: results from a large web-based survey
EB Andrews et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Guanylyl cyclase C as a reliable immunohistochemical marker and its ligand Escherichia coli heat-stable enterotoxin as a potential protein-delivering vehicle for colorectal cancer cells
E Buc et al.
EUROPEAN JOURNAL OF CANCER (2005)
Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact
APS Hungin et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Diagnosis of irritable bowel syndrome
BD Cash et al.
GASTROENTEROLOGY CLINICS OF NORTH AMERICA (2005)
Drug therapy - Systemic therapy for colorectal cancer
JA Meyerhardt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Guanylyl cyclase C is a marker of intestinal metaplasia, dysplasia, and adenocarcinoma of the gastrointestinal tract
R Birbe et al.
HUMAN PATHOLOGY (2005)
Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues
JR Mora et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
The health-related quality of life and economic burden of constipation
C Dennison et al.
PHARMACOECONOMICS (2005)
Epidemiology of constipation in North America: A systematic review
PDR Higgins et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Immunobiology of mucosal HIV infection and the basis for development of a new generation of mucosal AIDS vaccines
IM Belyakov et al.
IMMUNITY (2004)
American society of clinical oncology recommendations on adjuvant chemotherapy for stage II colon cancer
AB Benson et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties
MF Giblin et al.
BIOCONJUGATE CHEMISTRY (2004)
Impact of anal incontinence and chronic constipation on quality of life
H Damon et al.
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE (2004)
Mitochondrial biogenesis by NO yields functionally active mitochondria in mammals
E Nisoli et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer
T Andre et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptor
SL Carrithers et al.
KIDNEY INTERNATIONAL (2004)
Cyclic GMP transporters
G Sager
NEUROCHEMISTRY INTERNATIONAL (2004)
Uroguanylin and guanylin peptides: pharmacology and experimental therapeutics
LR Forte
PHARMACOLOGY & THERAPEUTICS (2004)
The staging of colorectal cancer: 2004 and beyond
CC Compton et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2004)
Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer:: Who benefits and by how much?
S Gill et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Δ716 Cdx2+/- compound mutant mice
K Aoki et al.
NATURE GENETICS (2003)
The economic consequences of irritable bowel syndrome - A US employer perspective
SA Leong et al.
ARCHIVES OF INTERNAL MEDICINE (2003)
Bacterial enterotoxins are associated with resistance to colon cancer
GM Pitari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The effect of new diagnostic criteria for irritable bowel syndrome on community prevalence estimates
YA Saito et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2003)
Native and recombinant proguanylin feature identical biophysical properties and are monomeric in solution
T Lauber et al.
BIOCHEMISTRY (2002)
Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation
KA Steinbrecher et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Molecular imaging of cancer with positron emission tomography
SS Gambhir
NATURE REVIEWS CANCER (2002)
Chemical synthesis of Escherichia coli analogues by regioselective disulfide bond formation: Biological evaluation of an (111)in-DOTA-Phe(19)-STh analogue for specific targeting of human colon cancers
H Gali et al.
BIOCONJUGATE CHEMISTRY (2002)
The enemy within: Keeping self-reactive T cells at bay in the periphery
LSK Walker et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Requirement of Math1 for secretory cell lineage commitment in the mouse intestine
Q Yang et al.
SCIENCE (2001)
Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome
U Wahnschaffe et al.
GASTROENTEROLOGY (2001)
Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent
KA Steinbrecher et al.
GASTROENTEROLOGY (2001)
Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells
GM Pitari et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Economic burden of irritable bowel syndrome - Proposed strategies to control expenditures
M Camilleri et al.
PHARMACOECONOMICS (2000)
The impact of irritable bowel syndrome on health-related quality of life
IM Gralnek et al.
GASTROENTEROLOGY (2000)
分享论文
